{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:56:20Z","timestamp":1788357380760,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2020NCKXBR"],"award-info":[{"award-number":["PRIN 2020NCKXBR"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02308-3","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T13:02:06Z","timestamp":1708002126000},"page":"1881-1886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-642X","authenticated-orcid":false,"given":"G.","family":"Ceccarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pelosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tyutyusheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Magno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bertelloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"1","key":"2308_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","volume":"42","author":"D Araujo-Vilar","year":"2019","unstructured":"Araujo-Vilar D, Santini F (2019) Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest 42(1):61\u201367","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2308_CR2","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A (2011) Clinical review: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 96(11):3313\u20133325","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2308_CR3","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT et al (2016) The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab 101(12):4500\u20134511","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2308_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","volume":"19","author":"Y Handelsman","year":"2013","unstructured":"Handelsman Y, Oral EA, Bloomgarden ZT et al (2013) The clinical approach to the detection of lipodystrophy\u2014an AACE consensus statement. Endocr Pract 19(1):107\u2013116","journal-title":"Endocr Pract"},{"issue":"2","key":"2308_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","volume":"15","author":"MC Foss-Freitas","year":"2020","unstructured":"Foss-Freitas MC, Akinci B, Luo Y et al (2020) Diagnostic strategies and clinical management of lipodystrophy. Expert Rev Endocrinol Metab 15(2):95\u2013114","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"2308_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2021.104073","volume":"50","author":"G Ceccarini","year":"2021","unstructured":"Ceccarini G, Magno S, Gilio D et al (2021) Autoimmunity in lipodystrophy syndromes. Presse Med 50(3):104073. https:\/\/doi.org\/10.1016\/j.lpm.2021.104073","journal-title":"Presse Med"},{"key":"2308_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang Y, Proenca R, Maffei M et al (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425\u2013432. https:\/\/doi.org\/10.1038\/372425a0","journal-title":"Nature"},{"key":"2308_CR8","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer PE, Williams S, Fogliano M et al (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746\u201326749","journal-title":"J Biol Chem"},{"issue":"5","key":"2308_CR9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","volume":"87","author":"WA Haque","year":"2002","unstructured":"Haque WA, Shimomura I, Matsuzawa Y et al (2002) Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87(5):2395. https:\/\/doi.org\/10.1210\/jcem.87.5.8624","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2308_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40337-017-0186-7","volume":"28","author":"C Lindvall Dahlgren","year":"2017","unstructured":"Lindvall Dahlgren C, Wisting L, R\u00f8 \u00d8J (2017) Feeding and eating disorders in the DSM-5 era: a systematic review of prevalence rates in non-clinical male and female samples. Eat Disord 28(5):56. https:\/\/doi.org\/10.1186\/s40337-017-0186-7","journal-title":"Eat Disord"},{"issue":"4","key":"2308_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s42000-022-00386-7","volume":"21","author":"D Ara\u00fajo-Vilar","year":"2022","unstructured":"Ara\u00fajo-Vilar D, Fern\u00e1ndez-Pombo A, Cobelo-G\u00f3mez S et al (2022) Lipodystrophy-associated progeroid syndromes. Hormones (Athens) 21(4):555\u2013571. https:\/\/doi.org\/10.1007\/s42000-022-00386-7","journal-title":"Hormones (Athens)"},{"issue":"10","key":"2308_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa108","volume":"4","author":"S Magno","year":"2020","unstructured":"Magno S, Ceccarini G, Pelosini C et al (2020) Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation. J Endocr Soc 4(10):bvaa108. https:\/\/doi.org\/10.1210\/jendso\/bvaa108","journal-title":"J Endocr Soc"},{"key":"2308_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-022-01795-6","volume":"6","author":"G Ceccarini","year":"2022","unstructured":"Ceccarini G, Gilio D, Magno S et al (2022) Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p. R349W mutation. J Endocrinol Invest 6:1\u20137. https:\/\/doi.org\/10.1007\/s40618-022-01795-6","journal-title":"J Endocrinol Invest"},{"issue":"9382","key":"2308_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","volume":"362","author":"L Chen","year":"2003","unstructured":"Chen L, Lee L, Kudlow BA et al (2003) LMNA mutations in atypical Werner\u2019s syndrome. Lancet 362(9382):440\u2013445. https:\/\/doi.org\/10.1016\/S0140-6736(03)14069-X","journal-title":"Lancet"},{"issue":"11","key":"2308_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.metabol.2014.07.010","volume":"63","author":"C Pelosini","year":"2014","unstructured":"Pelosini C, Martinelli S, Ceccarini G et al (2014) Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome. Metabolism 63(11):1385\u20131389. https:\/\/doi.org\/10.1016\/j.metabol.2014.07.010","journal-title":"Metabolism"},{"issue":"9","key":"2308_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86870","volume":"1","author":"A Garg","year":"2016","unstructured":"Garg A, Sankella S, Xing C et al (2016) Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy. JCI Insight 1(9):e86870. https:\/\/doi.org\/10.1172\/jci.insight.86870","journal-title":"JCI Insight"},{"issue":"2","key":"2308_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","volume":"54","author":"C Guill\u00edn-Amarelle","year":"2016","unstructured":"Guill\u00edn-Amarelle C, S\u00e1nchez-Iglesias S, Castro-Pais A et al (2016) (2016) Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome. Endocrine 54(2):411\u2013421. https:\/\/doi.org\/10.1007\/s12020-016-1002-x","journal-title":"Endocrine"},{"issue":"5","key":"2308_CR18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/jcm10051142","volume":"10","author":"S Magno","year":"2021","unstructured":"Magno S, Ceccarini G, Barison A et al (2021) Partial lipodystrophy and LMNA pR545H variant. J Clin Med 10(5):1142. https:\/\/doi.org\/10.3390\/jcm10051142","journal-title":"J Clin Med"},{"key":"2308_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad700","author":"S Magno","year":"2023","unstructured":"Magno S, Ceccarini G, Corvillo F et al (2023) Clinical characteristics of patients with acquired partial lipodystrophy: a multicenter retrospective study. Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad700","journal-title":"Clin Endocrinol Metab"},{"issue":"8","key":"2308_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/jcm10081559","volume":"10","author":"D Tews","year":"2021","unstructured":"Tews D, Schulz A, Denzer C et al (2021) Lipodystrophy as a late effect after stem cell transplantation. J Clin Med 10(8):1559. https:\/\/doi.org\/10.3390\/jcm10081559","journal-title":"J Clin Med"},{"issue":"6704","key":"2308_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704):763\u2013770. https:\/\/doi.org\/10.1038\/27376","journal-title":"Nature"},{"key":"2308_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, Halaas J, Ravussin E et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155\u20131161. https:\/\/doi.org\/10.1038\/nm1195-1155","journal-title":"Nat Med"},{"key":"2308_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439\u2013451","journal-title":"Endocr Rev"},{"key":"2308_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.5551\/jat.6106","volume":"17","author":"H Hirose","year":"2010","unstructured":"Hirose H, Yamamoto Y, Seino-Yoshihara Y et al (2010) Serum highmolecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb 17:1201\u20131211","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"2308_CR25","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1210\/jc.2003-031260","volume":"89","author":"T Tagami","year":"2004","unstructured":"Tagami T, Satoh N, Usui T et al (2004) Adiponectin in anorexia and bulimia nervosa. J Clin Endocrinol Metab 89(4):1833\u20131837. https:\/\/doi.org\/10.1210\/jc.2003-031260","journal-title":"J Clin Endocrinol Metab"},{"key":"2308_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1055\/s-2003-42655","volume":"35","author":"H Iwahashi","year":"2003","unstructured":"Iwahashi H, Funahashi T, Kurokawa N et al (2003) Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res 35:537\u2013540","journal-title":"Horm Metab Res"},{"key":"2308_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1046\/j.1365-2265.2003.01702.x","volume":"58","author":"ML Delporte","year":"2003","unstructured":"Delporte ML, Brichard SM, Hermans MP et al (2003) Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 58:22\u201329","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2308_CR28","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1210\/jc.2002-021215","volume":"88","author":"N Pannacciulli","year":"2003","unstructured":"Pannacciulli N, Vettor R, Milan G et al (2003) Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88:1748\u20131752","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2308_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1210\/jc.2004-1364","volume":"90","author":"J Housova","year":"2005","unstructured":"Housova J, Anderlova K, Krizov\u00e1 J et al (2005) Serum adiponectin and resistin concentrations in patients with restrictive and binge\/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90(3):1366\u20131370. https:\/\/doi.org\/10.1210\/jc.2004-1364","journal-title":"J Clin Endocrinol Metab"},{"key":"2308_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104485","volume":"112","author":"V Karageorgiou","year":"2020","unstructured":"Karageorgiou V, Furukawa TA, Tsigkaropoulou E et al (2020) Adipokines in anorexia nervosa: a systematic review and meta-analysis. Psychoneuroendocrinology 112:104485. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104485","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"2308_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2014.06.003","volume":"20","author":"WP Cawthorn","year":"2014","unstructured":"Cawthorn WP, Scheller EL, Learman BS et al (2014) Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab 20(2):368\u2013375. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.003","journal-title":"Cell Metab"},{"issue":"1","key":"2308_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.nut.2012.07.011","volume":"29","author":"H Amitani","year":"2013","unstructured":"Amitani H, Asakawa A, Ogiso K et al (2013) The role of adiponectin multimers in anorexia nervosa. Nutrition 29(1):203\u2013206. https:\/\/doi.org\/10.1016\/j.nut.2012.07.011","journal-title":"Nutrition"},{"issue":"3","key":"2308_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1210\/jc.2009-1824","volume":"95","author":"B Antuna-Puente","year":"2010","unstructured":"Antuna-Puente B, Boutet E, Vigouroux C et al (2010) Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab. 95(3):1463\u20131468. https:\/\/doi.org\/10.1210\/jc.2009-1824. (PMID: 20097706)","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2308_CR34","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.biochi.2012.01.021","volume":"94","author":"MP Groeneveld","year":"2012","unstructured":"Groeneveld MP, Huang-Doran I, Semple RK (2012) Adiponectin and leptin in human severe insulin resistance-diagnostic utility and biological insights. Biochimie. 94(10):2172\u20132179. https:\/\/doi.org\/10.1016\/j.biochi.2012.01.021. (PMID: 22342226)","journal-title":"Biochimie"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02308-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T02:07:11Z","timestamp":1721786831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02308-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02308-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GC has received fees for consulting and\/or received travel funds or participated in studies from the following companies, which are involved with lipodystrophy and\/or diabetes: Aegerion\/Amryt Pharmaceuticals, Novo-Nordisk, and Rhythm Pharmaceuticals. SM and CP\u00a0received travel funds from the following company, which was involved with lipodystrophy: Amryt Pharmaceuticals. FS has worked as a consultant, participated in studies, and\/or received travel funds from the following companies, which are involved with lipodystrophy and\/or diabetes: Aegerion\/Amryt, Novo Nordisk, Lilly, Bruno Pharma, and Pfizer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and agreed to the published article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving animals"}}]}}